AXIN1 and hepatocellular carcinoma: AXIN1 deficiency activates WNT/β-catenin signaling, TGFβ signaling, and YAP/TAZ, but only inhibiting YAP/TAZ can curtail hepatocellular carcinoma resulting from AXIN1 deficiency [115, 116, 193, 194].